声称可延缓阿尔茨海默病进程的药物获FDA批准

  • 打印
  • 收藏
收藏成功

In early July, FDA granted traditional full approval of Leqembi for the treatment of Alzheimer’s disease (AD). This is the first approved medication p(剩余4142字)

monitor